219 related articles for article (PubMed ID: 12040355)
21. Prevention of radiocontrast-induced nephropathy.
Asif A; Epstein M
Am J Kidney Dis; 2004 Jul; 44(1):12-24. PubMed ID: 15211433
[TBL] [Abstract][Full Text] [Related]
22. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus.
Weisberg LS; Kurnik PB; Kurnik BR
Kidney Int; 1994 Jan; 45(1):259-65. PubMed ID: 8127017
[TBL] [Abstract][Full Text] [Related]
23. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study.
Cogliati AA; Vellutini R; Nardini A; Urovi S; Hamdan M; Landoni G; Guelfi P
J Cardiothorac Vasc Anesth; 2007 Dec; 21(6):847-50. PubMed ID: 18068064
[TBL] [Abstract][Full Text] [Related]
24. Direct infusion of fenoldopam into the renal arteries to protect against contrast-induced nephropathy in patients at increased risk.
Talati S; Kirtane AJ; Hassanin A; Mehran R; Leon MB; Moses JW; Weisz G
Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):506-9. PubMed ID: 22469256
[TBL] [Abstract][Full Text] [Related]
25. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
Ranucci M; Soro G; Barzaghi N; Locatelli A; Giordano G; Vavassori A; Manzato A; Melchiorri C; Bove T; Juliano G; Uslenghi MF
Ann Thorac Surg; 2004 Oct; 78(4):1332-7; discussion 1337-8. PubMed ID: 15464494
[TBL] [Abstract][Full Text] [Related]
26. Pathophysiology of radiocontrast nephropathy and use of fenoldopam for its prevention.
Mathur VS
Rev Cardiovasc Med; 2001; 2 Suppl 1():S4-8. PubMed ID: 12439361
[TBL] [Abstract][Full Text] [Related]
27. Use of fenoldopam for prevention of radiocontrast nephropathy in the cardiac catheterization laboratory: a case series.
Madyoon H; Croushore L
J Interv Cardiol; 2001 Apr; 14(2):179-85. PubMed ID: 12053301
[TBL] [Abstract][Full Text] [Related]
28. Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).
Ng TM; Shurmur SW; Silver M; Nissen LR; O'Leary EL; Rigmaiden RS; Cieciorka M; Porter LL; Ineck BA; Kline ME; Puumala SE
Int J Cardiol; 2006 May; 109(3):322-8. PubMed ID: 16039733
[TBL] [Abstract][Full Text] [Related]
29. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
30. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.
Asif A; Epstein DL; Epstein M
J Clin Pharmacol; 2004 Dec; 44(12):1342-51. PubMed ID: 15545304
[TBL] [Abstract][Full Text] [Related]
31. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography.
Manske CL; Sprafka JM; Strony JT; Wang Y
Am J Med; 1990 Nov; 89(5):615-20. PubMed ID: 2239981
[TBL] [Abstract][Full Text] [Related]
32. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.
Rashid ST; Salman M; Myint F; Baker DM; Agarwal S; Sweny P; Hamilton G
J Vasc Surg; 2004 Dec; 40(6):1136-41. PubMed ID: 15622367
[TBL] [Abstract][Full Text] [Related]
33. [Fenoldopam: potential clinical applications in heart surgery].
Shorten GD
Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):487-91. PubMed ID: 11792308
[TBL] [Abstract][Full Text] [Related]
34. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
Vasheghani-Farahani A; Sadigh G; Kassaian SE; Khatami SM; Fotouhi A; Razavi SA; Mansournia MA; Yamini-Sharif A; Amirzadegan A; Salarifar M; Sadeghian S; Davoodi G; Borumand MA; Esfehani FA; Darabian S
Am J Kidney Dis; 2009 Oct; 54(4):610-8. PubMed ID: 19619921
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
36. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting.
Halpenny M; Lakshmi S; O'Donnell A; O'Callaghan-Enright S; Shorten GD
Anaesthesia; 2001 Oct; 56(10):953-60. PubMed ID: 11576097
[TBL] [Abstract][Full Text] [Related]
37. Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled study.
Sketch MH; Whelton A; Schollmayer E; Koch JA; Bernink PJ; Woltering F; Brinker J;
Am J Ther; 2001; 8(3):155-62. PubMed ID: 11344383
[TBL] [Abstract][Full Text] [Related]
38. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
39. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
Huber W; Ilgmann K; Page M; Hennig M; Schweigart U; Jeschke B; Lutilsky L; Weiss W; Salmhofer H; Classen M
Radiology; 2002 Jun; 223(3):772-9. PubMed ID: 12034949
[TBL] [Abstract][Full Text] [Related]
40. Radiocontrast-induced acute renal failure.
Weisbord SD; Palevsky PM
J Intensive Care Med; 2005; 20(2):63-75. PubMed ID: 15855219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
